Market Cap 59.61M
Revenue (ttm) 154.90M
Net Income (ttm) -20.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13.04%
Debt to Equity Ratio 15.74
Volume 1,106,400
Avg Vol 2,482,848
Day's Range N/A - N/A
Shares Out 189.85M
Stochastic %K 24%
Beta 1.61
Analysts Hold
Price Target $2.00

Company Profile

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed na...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 251 4400
Address:
25 Fenton Main Street, Suite 300, Cary, United States
ONLYPHARMS
ONLYPHARMS Sep. 17 at 10:31 AM
$HRTX @Tacto so how can they make a shell game out of stock options? This is pretty messed up. it’s like being hustled on the street corner in New York City 
1 · Reply
Tacto
Tacto Sep. 17 at 12:28 AM
$HRTX And there you have it - they moved the 2.1M from September to October, on the Put side of that $0.50 Strike . .
1 · Reply
Tacto
Tacto Sep. 17 at 12:24 AM
$HRTX On September options, the entire 2.1M (21k x 100) on the Put side was turned over today, for the $0.50 Strike, as in the whole f'n thing! Interesting, indeed! . .
0 · Reply
keypatience
keypatience Sep. 16 at 6:51 PM
$HRTX Shitty numbers @Braddog
0 · Reply
Tomtom13
Tomtom13 Sep. 16 at 2:52 AM
$HRTX all in
1 · Reply
Tacto
Tacto Sep. 15 at 11:34 PM
$HRTX If you look at options activity, there has basically been nothing going on there for months, as if an M&A agreement was all but formalized even before the August ER & business update. Something is certainly brewing behind the scenes. We can see the signs so clearly, that's for sure, as nothing could be as glaringly skewed as HRTX activity, or inactivity, for that matter. Tick tock, tick tock.....
1 · Reply
Tacto
Tacto Sep. 15 at 11:22 PM
$HRTX Interesting Stochastic trace in the lower part of the picture below. They didn't let it cross above the 80% Overbought line last week, before bringing it back down, and now they are starting to turn it for a move upward even before it has reached the 20% Oversold line. . . .
0 · Reply
Tacto
Tacto Sep. 15 at 10:52 PM
$HRTX Daily short volume was reported to be a whopping 73% today, and availability in the shorting pool was taken from 3.2M to ZERO this morning, and it's still at ZERO now Very strange stuff going on with these crime syndicate operators. On-Balance Volume was ZERO from the 9:30am opening bell until 2:48pm, which is not something I recall ever seeing here. And, Order Flow was very much on the positive side - Inflow: 140.44 Outflow: 80.76 . . .
0 · Reply
BullMaven
BullMaven Sep. 15 at 2:27 PM
$HRTX squeeze will happen sooner or later
1 · Reply
Noname2022
Noname2022 Sep. 14 at 11:30 PM
$CRMD $HRTX Pure speculation… https://stockanalysis.com/stocks/hrtx/transcripts/665944-q2-2026/ https://stockanalysis.com/stocks/crmd/transcripts/743296-wells-fargo-21st-annual-healthcare-conference/
0 · Reply
Latest News on HRTX
Heron Therapeutics Earnings Call Transcript: Q2 2026

Aug 10, 2026, 8:30 AM EDT - 5 weeks ago

Heron Therapeutics Earnings Call Transcript: Q2 2026


Heron Therapeutics Earnings release: Q2 2026

Aug 10, 2026, 8:30 AM EDT - 5 weeks ago

Heron Therapeutics Earnings release: Q2 2026


Heron Therapeutics Quarterly report: Q2 2026

Aug 10, 2026, 8:30 AM EDT - 5 weeks ago

Heron Therapeutics Quarterly report: Q2 2026


Heron Therapeutics Transcript: AGM 2026

Jun 11, 2026, 9:00 AM EDT - 3 months ago

Heron Therapeutics Transcript: AGM 2026


Heron Therapeutics downgraded to Hold from Buy at Needham

2026-06-02T20:07:25.000Z - 3 months ago

Heron Therapeutics downgraded to Hold from Buy at Needham

HRTX


Heron Therapeutics reports Q1 EPS (4c), consensus (2c)

2026-05-11T16:41:43.000Z - 4 months ago

Heron Therapeutics reports Q1 EPS (4c), consensus (2c)

HRTX


Heron Therapeutics Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Heron Therapeutics Earnings Call Transcript: Q1 2026


Heron Therapeutics Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Heron Therapeutics Earnings release: Q1 2026


Heron Therapeutics Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Heron Therapeutics Quarterly report: Q1 2026


Heron Therapeutics Slides: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Heron Therapeutics Slides: Q1 2026


Heron Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Heron Therapeutics Proxy statement: Proxy filing


Heron Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Heron Therapeutics Proxy statement: Proxy filing


Heron Therapeutics Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 5 months ago

Heron Therapeutics Proxy statement: Proxy filing


Heron Therapeutics Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Heron Therapeutics Earnings Call Transcript: Q4 2025


Heron Therapeutics Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Heron Therapeutics Annual report: Q4 2025


Heron Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Heron Therapeutics Earnings release: Q4 2025


Heron Therapeutics Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Heron Therapeutics Slides: Q4 2025


Heron Therapeutics reports Q4 EPS (2c) vs 2c last year

2026-02-26T13:22:25.000Z - 6 months ago

Heron Therapeutics reports Q4 EPS (2c) vs 2c last year

HRTX


Heron Therapeutics sees FY26 revenue $173M-$183M

2026-02-26T13:22:12.000Z - 6 months ago

Heron Therapeutics sees FY26 revenue $173M-$183M

HRTX


Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M

2026-01-09T14:35:13.000Z - 8 months ago

Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M

HRTX


Heron Therapeutics Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Heron Therapeutics Earnings Call Transcript: Q3 2025


Heron Therapeutics Quarterly report: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Heron Therapeutics Quarterly report: Q3 2025


Heron Therapeutics Earnings release: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Heron Therapeutics Earnings release: Q3 2025


Heron Therapeutics Slides: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Heron Therapeutics Slides: Q3 2025


Heron Therapeutics reports Q3 EPS (10c), consensus (1c)

2025-11-04T13:05:21.000Z - 10 months ago

Heron Therapeutics reports Q3 EPS (10c), consensus (1c)

HRTX


Heron Therapeutics Proxy statement: Proxy Filing

Sep 19, 2025, 8:00 AM EDT - 12 months ago

Heron Therapeutics Proxy statement: Proxy Filing


Heron Therapeutics files $125M mixed securities shelf

2025-09-09T21:15:15.000Z - 1 year ago

Heron Therapeutics files $125M mixed securities shelf

HRTX


Heron Therapeutics Proxy statement: Proxy Filing

Sep 9, 2025, 8:00 AM EDT - 1 year ago

Heron Therapeutics Proxy statement: Proxy Filing


Heron Therapeutics adopts tax benefits preservation plan

2025-08-15T11:50:16.000Z - 1 year ago

Heron Therapeutics adopts tax benefits preservation plan

HRTX


Heron Therapeutics Earnings Call Transcript: Q2 2025

Aug 8, 2025, 8:30 AM EDT - 1 year ago

Heron Therapeutics Earnings Call Transcript: Q2 2025


Heron Therapeutics Quarterly report: Q2 2025

Aug 8, 2025, 8:30 AM EDT - 1 year ago

Heron Therapeutics Quarterly report: Q2 2025


Heron Therapeutics Earnings release: Q2 2025

Aug 8, 2025, 8:30 AM EDT - 1 year ago

Heron Therapeutics Earnings release: Q2 2025


Heron Therapeutics Slides: Q2 2025

Aug 8, 2025, 8:30 AM EDT - 1 year ago

Heron Therapeutics Slides: Q2 2025


Heron Therapeutics Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Heron Therapeutics Earnings Call Transcript: Q1 2025


Heron Therapeutics Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Heron Therapeutics Earnings release: Q1 2025


Heron Therapeutics Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Heron Therapeutics Quarterly report: Q1 2025


Heron Therapeutics Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Heron Therapeutics Slides: Q1 2025


Heron Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Heron Therapeutics Proxy statement: Proxy Filing


Heron Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Heron Therapeutics Proxy statement: Proxy Filing


Heron Therapeutics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Heron Therapeutics Earnings Call Transcript: Q4 2024


Heron Therapeutics Annual report: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Heron Therapeutics Annual report: Q4 2024


Heron Therapeutics Earnings release: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Heron Therapeutics Earnings release: Q4 2024


Heron Therapeutics Slides: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Heron Therapeutics Slides: Q4 2024


Heron Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Heron Therapeutics Earnings Call Transcript: Q3 2024


Heron Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Heron Therapeutics Quarterly report: Q3 2024


Heron Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Heron Therapeutics Earnings release: Q3 2024


Heron Therapeutics Slides: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Heron Therapeutics Slides: Q3 2024


Heron Therapeutics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Earnings Call Transcript: Q2 2024


Heron Therapeutics Quarterly report: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Quarterly report: Q2 2024


Heron Therapeutics Earnings release: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Earnings release: Q2 2024


Heron Therapeutics Slides: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Slides: Q2 2024


Heron Therapeutics Transcript: Investor Day 2024

May 15, 2024, 9:30 AM EDT - 2 years ago

Heron Therapeutics Transcript: Investor Day 2024


Heron Therapeutics Slides: FY 2024

May 15, 2024, 9:30 AM EDT - 2 years ago

Heron Therapeutics Slides: FY 2024


Heron Therapeutics Earnings Call Transcript: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Heron Therapeutics Earnings Call Transcript: Q1 2024


Heron Therapeutics Quarterly report: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Heron Therapeutics Quarterly report: Q1 2024


Heron Therapeutics Earnings release: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Heron Therapeutics Earnings release: Q1 2024


Heron Therapeutics Slides: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Heron Therapeutics Slides: Q1 2024


Heron Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Heron Therapeutics Proxy statement: Proxy Filing


Heron Therapeutics Proxy statement: Proxy Filing

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Heron Therapeutics Proxy statement: Proxy Filing


Heron Therapeutics Earnings Call Transcript: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Earnings Call Transcript: Q4 2023


Heron Therapeutics Annual report: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Annual report: Q4 2023


Heron Therapeutics Earnings release: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Earnings release: Q4 2023


Heron Therapeutics Slides: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

Heron Therapeutics Slides: Q4 2023


Heron Therapeutics Earnings Call Transcript: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

Heron Therapeutics Earnings Call Transcript: Q3 2023


Heron Therapeutics Quarterly report: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

Heron Therapeutics Quarterly report: Q3 2023


Heron Therapeutics Earnings release: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

Heron Therapeutics Earnings release: Q3 2023


Heron Therapeutics Slides: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

Heron Therapeutics Slides: Q3 2023


Heron Therapeutics Registration statement: Registration Filing

Aug 23, 2023, 8:00 AM EDT - 3 years ago

Heron Therapeutics Registration statement: Registration Filing


Heron Therapeutics Earnings Call Transcript: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

Heron Therapeutics Earnings Call Transcript: Q2 2023


Heron Therapeutics Quarterly report: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

Heron Therapeutics Quarterly report: Q2 2023


Heron Therapeutics Earnings release: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

Heron Therapeutics Earnings release: Q2 2023


Heron Therapeutics Slides: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

Heron Therapeutics Slides: Q2 2023


ONLYPHARMS
ONLYPHARMS Sep. 17 at 10:31 AM
$HRTX @Tacto so how can they make a shell game out of stock options? This is pretty messed up. it’s like being hustled on the street corner in New York City 
1 · Reply
Tacto
Tacto Sep. 17 at 12:28 AM
$HRTX And there you have it - they moved the 2.1M from September to October, on the Put side of that $0.50 Strike . .
1 · Reply
Tacto
Tacto Sep. 17 at 12:24 AM
$HRTX On September options, the entire 2.1M (21k x 100) on the Put side was turned over today, for the $0.50 Strike, as in the whole f'n thing! Interesting, indeed! . .
0 · Reply
keypatience
keypatience Sep. 16 at 6:51 PM
$HRTX Shitty numbers @Braddog
0 · Reply
Tomtom13
Tomtom13 Sep. 16 at 2:52 AM
$HRTX all in
1 · Reply
Tacto
Tacto Sep. 15 at 11:34 PM
$HRTX If you look at options activity, there has basically been nothing going on there for months, as if an M&A agreement was all but formalized even before the August ER & business update. Something is certainly brewing behind the scenes. We can see the signs so clearly, that's for sure, as nothing could be as glaringly skewed as HRTX activity, or inactivity, for that matter. Tick tock, tick tock.....
1 · Reply
Tacto
Tacto Sep. 15 at 11:22 PM
$HRTX Interesting Stochastic trace in the lower part of the picture below. They didn't let it cross above the 80% Overbought line last week, before bringing it back down, and now they are starting to turn it for a move upward even before it has reached the 20% Oversold line. . . .
0 · Reply
Tacto
Tacto Sep. 15 at 10:52 PM
$HRTX Daily short volume was reported to be a whopping 73% today, and availability in the shorting pool was taken from 3.2M to ZERO this morning, and it's still at ZERO now Very strange stuff going on with these crime syndicate operators. On-Balance Volume was ZERO from the 9:30am opening bell until 2:48pm, which is not something I recall ever seeing here. And, Order Flow was very much on the positive side - Inflow: 140.44 Outflow: 80.76 . . .
0 · Reply
BullMaven
BullMaven Sep. 15 at 2:27 PM
$HRTX squeeze will happen sooner or later
1 · Reply
Noname2022
Noname2022 Sep. 14 at 11:30 PM
$CRMD $HRTX Pure speculation… https://stockanalysis.com/stocks/hrtx/transcripts/665944-q2-2026/ https://stockanalysis.com/stocks/crmd/transcripts/743296-wells-fargo-21st-annual-healthcare-conference/
0 · Reply
Caribbe
Caribbe Sep. 14 at 4:17 PM
$HRTX This will be a very interesting end of the week.
1 · Reply
Sdwg
Sdwg Sep. 14 at 12:48 PM
$HRTX those 21k sept 0.5 puts going to get assigned to someone Friday unless this pops...
0 · Reply
bullishonHRTX
bullishonHRTX Sep. 14 at 12:29 PM
$HRTX any update on $4 million debt repayment to Hercules. i guess deadline is tomorrow. hopefully we hear about that soon.
1 · Reply
afindling
afindling Sep. 14 at 12:27 PM
$HRTX good morning anyone have the monthly numbers? Thanks in advance
0 · Reply
Tacto
Tacto Sep. 14 at 4:28 AM
$HRTX @Baddong @Chancypoo @RestOfFUDPuppetGallery . . .
0 · Reply
Braddog
Braddog Sep. 14 at 2:35 AM
$HRTX TACO is Collard’s pansy
0 · Reply
Tacto
Tacto Sep. 14 at 12:04 AM
$HRTX LOL
0 · Reply
Braddog
Braddog Sep. 13 at 11:54 PM
$HRTX Taco You have your head so far up your ass that you’ve mistaken bullshit for reality.
0 · Reply
Tacto
Tacto Sep. 13 at 11:29 PM
$HRTX @Baddong @Chancypoo
0 · Reply
chance111
chance111 Sep. 13 at 12:20 PM
$HRTX I have a real and worthwhile recommendation for everyone on this site. Although heron is the only stock I have not made decent money on in the last 10 years, nobody should necessarily listen to what I say. Although I am an unbiased long and say what I believe, I am not always right. Most of the other people on here are completely unrealistic and not reliable. They believe what they want to believe. If you have a concern or question with regards to heron, you should consult many of the AI sites available. You will get an UNBIASED answer to any of the concerns you might have. It is a better source of information than the people on here with price targets of $15 or believe heron is going to $5 soon. It is better than listening to people referring to others as fud puppits or that @braddog and myself as one in the same. Just saying.
2 · Reply
chance111
chance111 Sep. 13 at 11:43 AM
$HRTX I realize AI is not always right, but they are more on target than anyone on this website. According to multiple sources, the likelyhood of a launch by azurity prior to resolution of appeal is 60-80 %
1 · Reply
Tacto
Tacto Sep. 11 at 10:47 PM
$HRTX Daily short volume was reported at a whopping 72% today, and you can see the swapping of the entire 3.3M in the shorting pool in the picture below, you just know that no genuine shares whatsoever traded hands today. Same old circle of bogusness, as the crime syndicate operators just tread water to delay their inevitable demise... Oh, and Fintel currently shows Retail ownership at a microscopic 0.0045%, while short interest on HRTX is ~45M, so it's hilarious that those ass-clowns have their FUD puppets working overtime on this primarily-retail forum, as if somehow getting that nanogram of Retail shares is gonna address the issue of that mammoth 45M heap of short interest, with Insiders & Institutions having all other genuine shares locked up super tight! LOL LOL LOL . . .
1 · Reply